Stocks or ETFs side by side: scores, returns, risk, valuation and what they hold.
| Measure | JNJJohnson & Johnson | NVSNovartis AG |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Country | United States | Switzerland |
| Market cap | $676B | $308B |
| Price | $280.78 | $163.26 |
| Last day | −0.47% | −0.26% |
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.
JNJ analysis and Q-Scores →Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS analysis and Q-Scores →Data as of 2026-10-13. Not investment advice.